Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-17

FDA Approved: PIOGLITAZONE — Original Application (Solco Healthcare LLC)

View source ↗

Summary

FDA approves Solco Healthcare LLC's original application for pioglitazone as a generic product under ANDA 207806.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIOGLITAZONE (Pioglitazone)

Snippet

ORIG AP for PIOGLITAZONE (PIOGLITAZONE)